Sign In
NewsRadar

Speedel

Speedel is a biopharmaceutical company that creates value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, an exciting new approach to treating cardiovascular diseases.

• Show past press releases
• Edit this company

Elevator Pitch
Speedel develops novel therapies through focused innovation and smart drug development from lead identification to the end of Phase II. We either partner with big pharma for Phase III and commercialisation of primary-care indications, or we may ouselves complete Phase III for specialist indications. Candidate compounds for development and the company's intellectual property come from our late-stage research unit Speedel Experimenta and from in-licensing.

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Hirschgässlein 11
Basel CH - 4051
Switzerland
+41 (0)61 206 40 00
+41 (0)61 206 40 01
http://www.speedel.com
Nick Miles
+41 (0)61 206 40 14

Company Facts
Founded:Dec 1998
Founders:Dr. Alice Huxley
CEO:Alice Huxley
CTO or technical lead:
CFO or finance director:Konrad P. Wirz
Head of Sales:
Head of Marketing:Ben T. G. Tan

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:60
Profitability:Not Profitable
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:Yes

Non-executive Board Members

  • Dr. Fritz Kunz, R & D Management , Sandoz Pharma
  • Dr. Marius Sutter, Strategic Planning & Investor Relations, Syngenta
  • Ralf Rosenow, attorney-at-law and partner of the law firm , Rosenow Grob Schilling in Zurich
  • Dr. Ernst Schweizer, Head of Business Development, Genmab

    Key Customers

  • Novartis
  • Roche

    Key Business Partners

  • Novartis
  • Roche
  • Locus Pharmaceuticals

    Key Competitors

  • Actelion
  • Myogen
  • Encysive

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    27,370
    Tech investments
    From our Online Data Service
    17,662
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Nov 25€24.0MInternet commerce
    Sep 13N/AWireless services
    Sep 11€0.3MInternet services
    Sep 10€25.0MBiopharmaceuticals
    Sep 10N/AInternet services
    Sep 10€25.0MBiotechnology
    Sep 10€1,700.0MGames

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Mar 31
    CompPair
    the fit allocates chf 100'000 to comppair technologies

    Jan 29
    Yumpingo
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.